Toyoki Kudo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Toyoki Kudo has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Masashi Misawa
Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan
6 shared publications - Shin-Ei Kudo
Digestive Disease Center, Showa Medical University Northern Yokohama Hospital, Yokohama, Japan
6 shared publications - Fumio Ishida
Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan
5 shared publications Naoya Toyoshima
Digestive Disease Center Showa University Northern Yokohama Hospital Kanagawa Japan
5 shared publications- Yuichi Mori
Department of Transplantation Medicine, Gastroenterology Section, Oslo University Hospital, Oslo, Norway
5 shared publications Kunihiko Wakamura
Digestive Disease Center Showa University Northern Yokohama Hospital Kanagawa Japan
4 shared publications
Latest Publications
- Open Access
Endoscopic submucosal dissection for colorectal neoplasms: Risk factors for local recurrence and long‐term surveillance
Objectives: Endoscopic submucosal dissection (ESD) is an effective procedure for the en bloc resection of colorectal neoplasms. However, risk factors for local recurrence after ESD have not been identified. This study aimed to evaluate such risk factors after ESD for colorectal neoplasms.Methods: This retrospective study included 1344 patients with 1539 consecutive colorectal lesions who underwent ESD between September 2003 and December 2019. We investigated various factors associated with local recurrence in these patients. The main outcomes were the incidence of local recurrence and its relationship with clinicopathological factors during long‐term surveillance.Results: The en bloc resection rate was 98.6%, the R0 resection rate was 97.2%, and the histologically complete resection rate was 92.7%. Local recurrence was observed in 7/1344 (0.5%) patients and the median follow‐up period was 72 months (range 4–195 months). The incidence of local recurrence was significantly higher in lesions ≥40 mm in diameter (hazard ratio [HR] 15.68 [1.88–130.5]; p = 0.011), piecemeal resection (HR 48.42 [10.7–218.7]; p < 0.001), non‐R0 resection (HR 41.05 [9.025–186.7]; p < 0.001), histologically incomplete resection (HR 16.23 [3.627–72.63]; pp = 0.037).Conclusions: Five risk factors for local recurrence after ESD were identified. Patients with such factors should undergo careful surveillance colonoscopy.
Open AccessEndoscopic submucosal dissection for colorectal neoplasms: Risk factors for local recurrence and long‐term surveillance
Objectives: Endoscopic submucosal dissection (ESD) is an effective procedure for the en bloc resection of colorectal neoplasms. However, risk factors for local recurrence after ESD have not been identified. This study aimed to evaluate such risk factors after ESD for colorectal neoplasms.Methods: This retrospective study included 1344 patients with 1539 consecutive colorectal lesions who underwent ESD between September 2003 and December 2019. We investigated various factors associated with local recurrence in these patients. The main outcomes were the incidence of local recurrence and its relationship with clinicopathological factors during long‐term surveillance.Results: The en bloc resection rate was 98.6%, the R0 resection rate was 97.2%, and the histologically complete resection rate was 92.7%. Local recurrence was observed in 7/1344 (0.5%) patients and the median follow‐up period was 72 months (range 4–195 months). The incidence of local recurrence was significantly higher in lesions ≥40 mm in diameter (hazard ratio [HR] 15.68 [1.88–130.5]; p = 0.011), piecemeal resection (HR 48.42 [10.7–218.7]; p < 0.001), non‐R0 resection (HR 41.05 [9.025–186.7]; p < 0.001), histologically incomplete resection (HR 16.23 [3.627–72.63]; pp = 0.037).Conclusions: Five risk factors for local recurrence after ESD were identified. Patients with such factors should undergo careful surveillance colonoscopy.
- Open Access
- 30 July 2021
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 54 (4) , 455-463
Clinical Efficacy of Endocytoscopy for Gastrointestinal Endoscopy
Endocytoscopy (EC) is a contact-type optical endoscope that allows in vivo cellular observation during gastrointestinal endoscopy and is now commercially available not only in Japan but also in Asian, European Union, and Middle Eastern countries. EC helps conduct a highly accurate pathological prediction without biopsy. Initially, EC was reported to be effective for esophageal diseases. Subsequently, its efficacy for stomach and colorectal diseases has been reported. In this narrative review, we searched for clinical studies that investigated the efficacy of EC. EC seems to accurately diagnose gastrointestinal diseases without biopsy. Most of the studies aimed to clarify the relationship between endocytoscopic findings of gastrointestinal neoplasia and pathological diagnosis. Some studies have investigated non-epithelial lesions or diseases, such as inflammatory bowel disease or infectious diseases. However, there are few high-level pieces of evidence, such as randomized trials; thus, further studies are needed.
- 30 July 2021
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 54 (4) , 455-463
Open AccessClinical Efficacy of Endocytoscopy for Gastrointestinal Endoscopy
Endocytoscopy (EC) is a contact-type optical endoscope that allows in vivo cellular observation during gastrointestinal endoscopy and is now commercially available not only in Japan but also in Asian, European Union, and Middle Eastern countries. EC helps conduct a highly accurate pathological prediction without biopsy. Initially, EC was reported to be effective for esophageal diseases. Subsequently, its efficacy for stomach and colorectal diseases has been reported. In this narrative review, we searched for clinical studies that investigated the efficacy of EC. EC seems to accurately diagnose gastrointestinal diseases without biopsy. Most of the studies aimed to clarify the relationship between endocytoscopic findings of gastrointestinal neoplasia and pathological diagnosis. Some studies have investigated non-epithelial lesions or diseases, such as inflammatory bowel disease or infectious diseases. However, there are few high-level pieces of evidence, such as randomized trials; thus, further studies are needed.
- 1 March 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (4) , 1075-1084.e2
Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node
- 1 March 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (4) , 1075-1084.e2
Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node
- Top Cited Papers
- 1 July 2020
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (8) , 1874-1881.e2
Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms
- 1 July 2020
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (8) , 1874-1881.e2
Top Cited PapersArtificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms
- Open Access
- 28 September 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (6) , 7264-7270
Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion
With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the tumor cells within the colon wall. The aim of the present study was to reveal the clinicopathological features of T1 CRCs with SLVI and validate the Japanese guidelines regarding SLVI. A total of 741 patients with T1 CRCs that were resected surgically between April 2001 and October 2016 in our hospital were divided into two groups: With SLVI and without SLVI. Clinicopathological features compared between the two groups were patient's gender, age, tumor size, location, morphology, lymphovascular invasion, tumor differentiation, tumor budding and lymph node metastasis. The incidence of T1 CRCs with SLVI was 0.9% (7/741). All cases with SLVI were found in the sigmoid colon or rectum. T1 CRCs with SLVI showed significantly higher rates of lymphovascular invasion than those without SLVI (P<0.01). In conclusion, lymphovascular invasion was a significant risk factor for SLVI in T1 CRCs, and for which surgical colectomy was necessary. The Japanese guidelines are appropriate regarding SLVI. Registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000027097).
- 28 September 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (6) , 7264-7270
Open AccessClinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion
With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the tumor cells within the colon wall. The aim of the present study was to reveal the clinicopathological features of T1 CRCs with SLVI and validate the Japanese guidelines regarding SLVI. A total of 741 patients with T1 CRCs that were resected surgically between April 2001 and October 2016 in our hospital were divided into two groups: With SLVI and without SLVI. Clinicopathological features compared between the two groups were patient's gender, age, tumor size, location, morphology, lymphovascular invasion, tumor differentiation, tumor budding and lymph node metastasis. The incidence of T1 CRCs with SLVI was 0.9% (7/741). All cases with SLVI were found in the sigmoid colon or rectum. T1 CRCs with SLVI showed significantly higher rates of lymphovascular invasion than those without SLVI (P<0.01). In conclusion, lymphovascular invasion was a significant risk factor for SLVI in T1 CRCs, and for which surgical colectomy was necessary. The Japanese guidelines are appropriate regarding SLVI. Registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000027097).
- Top Cited PapersOpen Access
- 1 June 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (8) , 2027-2029.e3
Artificial Intelligence-Assisted Polyp Detection for Colonoscopy: Initial Experience
- 1 June 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (8) , 2027-2029.e3
Top Cited PapersOpen AccessArtificial Intelligence-Assisted Polyp Detection for Colonoscopy: Initial Experience
- Open Access
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB154
575 Narrow-Band Imaging Efficiency for Evaluation of Mucosal Healing/ Relapse of Ulcerative colitis
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB154
Open Access575 Narrow-Band Imaging Efficiency for Evaluation of Mucosal Healing/ Relapse of Ulcerative colitis
- 1 November 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 82 (5) , 912-923
Endocytoscopic microvasculature evaluation is a reliable new diagnostic method for colorectal lesions (with video)
- 1 November 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 82 (5) , 912-923
Endocytoscopic microvasculature evaluation is a reliable new diagnostic method for colorectal lesions (with video)